These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

822 related items for PubMed ID: 25490093

  • 1. p53-dependent activation of microRNA-34a in response to etoposide-induced DNA damage in osteosarcoma cell lines not impaired by dominant negative p53 expression.
    Novello C, Pazzaglia L, Conti A, Quattrini I, Pollino S, Perego P, Picci P, Benassi MS.
    PLoS One; 2014; 9(12):e114757. PubMed ID: 25490093
    [Abstract] [Full Text] [Related]

  • 2. microRNA-34a sensitizes lung cancer cell lines to DDP treatment independent of p53 status.
    Wang X, Dong K, Gao P, Long M, Lin F, Weng Y, Ouyang Y, Ren J, Zhang H.
    Cancer Biother Radiopharm; 2013 Feb; 28(1):45-50. PubMed ID: 23036084
    [Abstract] [Full Text] [Related]

  • 3. The miR-34a-5p promotes the multi-chemoresistance of osteosarcoma via repression of the AGTR1 gene.
    Pu Y, Zhao F, Li Y, Cui M, Wang H, Meng X, Cai S.
    BMC Cancer; 2017 Jan 10; 17(1):45. PubMed ID: 28073349
    [Abstract] [Full Text] [Related]

  • 4. Growth inhibition and sensitization to cisplatin by zoledronic acid in osteosarcoma cells.
    Benassi MS, Chiechi A, Ponticelli F, Pazzaglia L, Gamberi G, Zanella L, Manara MC, Perego P, Ferrari S, Picci P.
    Cancer Lett; 2007 Jun 08; 250(2):194-205. PubMed ID: 17113707
    [Abstract] [Full Text] [Related]

  • 5. Expression level of miR-34a rather than P53 gene status correlates with mutability in related human lymphoblast cell lines.
    Chen X, Yan J, Chen T.
    Mol Carcinog; 2012 Aug 08; 51(8):674-7. PubMed ID: 21809390
    [Abstract] [Full Text] [Related]

  • 6. Differential microRNA-34a expression and tumor suppressor function in retinoblastoma cells.
    Dalgard CL, Gonzalez M, deNiro JE, O'Brien JM.
    Invest Ophthalmol Vis Sci; 2009 Oct 08; 50(10):4542-51. PubMed ID: 19443717
    [Abstract] [Full Text] [Related]

  • 7. Altered miRNA and gene expression in acute myeloid leukemia with complex karyotype identify networks of prognostic relevance.
    Rücker FG, Russ AC, Cocciardi S, Kett H, Schlenk RF, Botzenhardt U, Langer C, Krauter J, Fröhling S, Schlegelberger B, Ganser A, Lichter P, Zenz T, Döhner H, Döhner K, Bullinger L.
    Leukemia; 2013 Feb 08; 27(2):353-61. PubMed ID: 22810507
    [Abstract] [Full Text] [Related]

  • 8. Mutant p53 gain of function can be at the root of dedifferentiation of human osteosarcoma MG63 cells into 3AB-OS cancer stem cells.
    Di Fiore R, Marcatti M, Drago-Ferrante R, D'Anneo A, Giuliano M, Carlisi D, De Blasio A, Querques F, Pastore L, Tesoriere G, Vento R.
    Bone; 2014 Mar 08; 60():198-212. PubMed ID: 24373920
    [Abstract] [Full Text] [Related]

  • 9. MicroRNA-34a: a novel tumor suppressor in p53-mutant glioma cell line U251.
    Luan S, Sun L, Huang F.
    Arch Med Res; 2010 Feb 08; 41(2):67-74. PubMed ID: 20470934
    [Abstract] [Full Text] [Related]

  • 10. Interferonalpha enhances etoposide-induced apoptosis in human osteosarcoma U2OS cells by a p53-dependent pathway.
    Yuan XW, Zhu XF, Liang SG, Fan Q, Chen ZX, Huang XF, Sheng PY, He AS, Yang ZB, Deng R, Feng GK, Liao WM.
    Life Sci; 2008 Feb 13; 82(7-8):393-401. PubMed ID: 18191951
    [Abstract] [Full Text] [Related]

  • 11. Long Noncoding RNA SNHG7 Promotes the Tumor Growth and Epithelial-to-Mesenchymal Transition via Regulation of miR-34a Signals in Osteosarcoma.
    Deng Y, Zhao F, Zhang Z, Sun F, Wang M.
    Cancer Biother Radiopharm; 2018 Nov 13; 33(9):365-372. PubMed ID: 29989838
    [Abstract] [Full Text] [Related]

  • 12. Growth inhibition and induction of apoptosis by flavopiridol in rat lung adenocarcinoma, osteosarcoma and malignant fibrous histiocytoma cell lines.
    Honoki K, Yoshitani K, Tsujiuchi T, Mori T, Tsutsumi M, Morishita T, Takakura Y, Mii Y.
    Oncol Rep; 2004 May 13; 11(5):1025-30. PubMed ID: 15069542
    [Abstract] [Full Text] [Related]

  • 13. Mevalonate pathway inhibitors affect anticancer drug-induced cell death and DNA damage response of human sarcoma cells.
    Nilsson S, Huelsenbeck J, Fritz G.
    Cancer Lett; 2011 May 01; 304(1):60-9. PubMed ID: 21356574
    [Abstract] [Full Text] [Related]

  • 14. TGF-β1-induced miR-202 mediates drug resistance by inhibiting apoptosis in human osteosarcoma.
    Lin Z, Song D, Wei H, Yang X, Liu T, Yan W, Xiao J.
    J Cancer Res Clin Oncol; 2016 Jan 01; 142(1):239-46. PubMed ID: 26276504
    [Abstract] [Full Text] [Related]

  • 15. The plant alkaloid cryptolepine induces p21WAF1/CIP1 and cell cycle arrest in a human osteosarcoma cell line.
    Matsui TA, Sowa Y, Murata H, Takagi K, Nakanishi R, Aoki S, Yoshikawa M, Kobayashi M, Sakabe T, Kubo T, Sakai T.
    Int J Oncol; 2007 Oct 01; 31(4):915-22. PubMed ID: 17786325
    [Abstract] [Full Text] [Related]

  • 16. Functional elucidation of MiR-34 in osteosarcoma cells and primary tumor samples.
    He C, Xiong J, Xu X, Lu W, Liu L, Xiao D, Wang D.
    Biochem Biophys Res Commun; 2009 Oct 09; 388(1):35-40. PubMed ID: 19632201
    [Abstract] [Full Text] [Related]

  • 17.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 18. Upregulation of miR-192 inhibits cell growth and invasion and induces cell apoptosis by targeting TCF7 in human osteosarcoma.
    Wang Y, Zhang S, Xu Y, Zhang Y, Guan H, Li X, Li Y, Wang Y.
    Tumour Biol; 2016 Nov 09; 37(11):15211-15220. PubMed ID: 27683056
    [Abstract] [Full Text] [Related]

  • 19. miR-375 targets the p53 gene to regulate cellular response to ionizing radiation and etoposide in gastric cancer cells.
    Liu Y, Xing R, Zhang X, Dong W, Zhang J, Yan Z, Li W, Cui J, Lu Y.
    DNA Repair (Amst); 2013 Sep 09; 12(9):741-50. PubMed ID: 23835407
    [Abstract] [Full Text] [Related]

  • 20. Expression and promotor hypermethylation of miR-34a in the various histological subtypes of ovarian cancer.
    Schmid G, Notaro S, Reimer D, Abdel-Azim S, Duggan-Peer M, Holly J, Fiegl H, Rössler J, Wiedemair A, Concin N, Altevogt P, Marth C, Zeimet AG.
    BMC Cancer; 2016 Feb 15; 16():102. PubMed ID: 26879132
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 42.